Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Current Assets
Cash and cash equivalents	$ 3,298	$ 6,722
Accounts receivable – net of related allowance for credit loss of $375 and $499	9,638	10,289
Inventories	2,270	2,177
Prepaid and other current assets	15,962	17,270
Total current assets	31,168	36,458
Property, Plant and Equipment – Net	128,871	128,489
Goodwill – Net	63,432	67,854
Licenses – Net	127,035	127,219
Other Intangible Assets – Net	5,255	5,283
Investments in and Advances to Equity Affiliates	295	1,251
Operating Lease Right-Of-Use Assets	20,909	20,905
Other Assets	17,830	19,601
Total Assets	394,795	407,060
Current Liabilities
Debt maturing within one year	5,089	9,477
Accounts payable and accrued liabilities	35,657	35,852
Advanced billings and customer deposits	4,099	3,778
Dividends payable	2,027	2,020
Total current liabilities	46,872	51,127
Long-Term Debt	118,443	127,854
Deferred Credits and Other Noncurrent Liabilities
Deferred income taxes	58,939	58,666
Postemployment benefit obligation	9,025	8,734
Operating lease liabilities	17,391	17,568
Other noncurrent liabilities	23,900	23,696
Total deferred credits and other noncurrent liabilities	109,255	108,664
Redeemable Noncontrolling Interest, Equity, Carrying Amount [Abstract]
Redeemable Noncontrolling Interest	1,980	1,973
Stockholders’ Equity
Common stock ($1 par value, 14,000,000,000 authorized at December 31, 2024 and December 31, 2023: issued 7,620,748,598 at December 31, 2024 and December 31, 2023)	7,621	7,621
Additional paid-in capital	109,108	114,519
Retained earnings (deficit)	1,871	(5,015)
Treasury stock (444,853,148 at December 31, 2024 and 470,685,237 at December 31, 2023, at cost)	(15,023)	(16,128)
Accumulated other comprehensive income	795	2,300
Noncontrolling interest	13,873	14,145
Total stockholders’ equity	118,245	117,442
Total Liabilities and Stockholders’ Equity	394,795	407,060
Series A (48,000 issued and outstanding at December 31, 2024 and December 31, 2023)
Stockholders’ Equity
Preferred stock ($1 par value, 10,000,000 authorized at December 31, 2024 and December 31, 2023):	0	0
Series B (20,000 issued and outstanding at December 31, 2024 and December 31, 2023)
Stockholders’ Equity
Preferred stock ($1 par value, 10,000,000 authorized at December 31, 2024 and December 31, 2023):	0	0
Series C (70,000 issued and outstanding at December 31, 2024 and December 31, 2023)
Stockholders’ Equity
Preferred stock ($1 par value, 10,000,000 authorized at December 31, 2024 and December 31, 2023):	$ 0	$ 0